New Orleans (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication. Abstracts 87-LB and 90-LB New findings from the two phase 3b SWITCH trials showed that treatment with long-acting basal insulin Tresiba® (insulin degludec injection ...
Shire Pharmaceuticals Group Plc
Zug, Switzerland (ots/PRNewswire) - - Cuvitru (IG 20mg/ml solution for subcutaneous injection) builds on company's broad portfolio of IG treatments gained through combination with Baxalta - New option to treat primary and certain secondary immunodeficiencies can help meet patient needs related to number of infusion ...
EQS Group-Ad-hoc: Sandpiper Digital Payments AG / Key word(s): Final Results/AGM/EGM SANDPIPER Digital Payments AG announces annual figures for 2015 10.06.2016 / 20:00 Release of an ad hoc announcement pursuant to Art. 18 KR. The issuer is solely responsible for the content of this announcement. 470853 10.06.2016 ...
London (ots/PRNewswire) - Reduction of weight limit to at least 30kg means more children and adolescents will be eligible for dolutegravir ViiV Healthcare today announced that the US Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for dolutegravir 10mg and 25mg oral ...
Brussels (ots/PRNewswire) - - Bimekizumab is a highly selective monoclonal antibody that inhibits the activity of both IL-17A and IL-17F, key pro-inflammatory cytokines expressed in several inflammatory diseases[1],[2] - In this early proof of concept study, bimekizumab showed fast and sustained efficacy on disease ...
Montréal (ots/PRNewswire) - Hydro-Québec has announced a move to attract data centres to Québec. The decision is in line with one of the objectives outlined in its Strategic Plan 2016-2020, namely to lay the groundwork to double the company's revenue over the next 15 years. "The global data centre market is rapidly growing and we have what it takes to be at the ...
DGAP-News: LION E-Mobility AG / Key word(s): Incoming Orders/Joint Venture LION E-Mobility AG: Join Venture 'TÜV SÜD Battery Testing GmbH' receives grant in highly remunerated EU funding project 08.06.2016 / 14:34 The issuer is solely responsible for the content of this announcement. 470161 08.06.2016 ...
Brussels (ots/PRNewswire) - For medical and trade media only. New data highlight breadth of UCB's pioneering portfolio with four molecules across five indications: - An oral presentation of data from the two year C-EARLY(TM) Phase 3 study of Cimzia®, exploring different dosing strategies - Oral presentations from ...
Lausanne, Switzerland (ots/PRNewswire) - Debiopharm today announced the start of a phase II clinical trial for Debio 1143 in combination with standard of care Carboplatin and Paclitaxel in Epithelial Ovarian Cancer Debiopharm International SA (Debiopharm), part of Debiopharm Group(TM), a Swiss-based global ...
New York (ots/PRNewswire) - DH Corporation (http://dh.com/) (TSX: DH) ("D+H"), a leading provider of technology solutions to financial institutions globally, today announced that Gene Neyer, D+H's head of product, global payments, will join a panel titled "How Mainstream Can Blockchain Be?" at EBAday, a leading forum covering the key trends impacting the payments industry, on June 7 in Milan, Italy. The panel, which ...
Bagsværd, Denmark (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication. Novo Nordisk, a global leader in diabetes care, today announced that data from 53 abstracts including 8 oral presentations will be shared at the upcoming 76th ...
DGAP-News: LION E-Mobility AG / Key word(s): Incoming Orders/Miscellaneous LION E-Mobility AG: LION Smart GmbH and consortium partners receive grant in highly remunerated EU funding project 06.06.2016 / 08:00 The issuer is solely responsible for the content of this announcement. 469249 06.06.2016 ...
Montreal (ots/PRNewswire) - - JSS Medical Research, an international contract research organization active in over 20 countries acquires Bonne Santé in Poland as catalyst for European expansion JSS Medical Research Inc., an International Contract Research Organization (CRO) with offices in Canada, Latin America and Asia/Pacific, announced the acquisition of Bonne Santé, a Polish CRO, to accelerate the expansion into ...
EQS Group-Ad-hoc: Jungfraubahn Holding AG / Key word(s): Change of Personnel Jungfraubahn Holding AG: Jürg Lauper to retire 04.06.2016 / 20:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 469227 04.06.2016 ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK- or US-based media - BEACON CRC trial will assess efficacy of combination regime Erbitux® (cetuximab), binimetinib and encorafenib in BRAF-mutant metastatic colorectal cancer (mCRC) Merck, a leading science and technology company, jointly announced with ...
issuer: Semperit AG Holding Modecenterstrasse 22 A-1030 Wien phone: +43 1 79 777-210 FAX: +43 1 79 777-602 mail: investor@semperitgroup.com WWW: www.semperitgroup.com sector: Synthetics & Plastics ISIN: AT0000785555 indexes: WBI, ATX Prime, ViDX, Prime Market, ATX Global Players stockmarkets: official market: Wien ...
issuer: S IMMO AG Friedrichstraße 10 A-1010 Wien phone: +43(0)50100-27550 FAX: +43(0)050100-927559 mail: office@simmoag.at WWW: www.simmoag.at sector: Real Estate ISIN: AT0000652250 indexes: ATX Prime, IATX stockmarkets: official market: Wien language: English ...
London (ots/PRNewswire) - The Company confirms that at its General Meeting held on 3 June in Amsterdam, all resolutions were duly passed. Contacts: Jacob Broekhuijsen - CEO +44(0)203-728-4450 or ...
EQS Group-Ad-hoc: shaPE Capital AG / Key word(s): Final Results/AGM/EGM shaPE Capital AG in liquidation - Annual report 2015, further CHF 10 per share distribution to shareholders, and invitation to ordinary shareholder meeting 2016 03.06.2016 / 09:45 Release of an ad hoc announcement pursuant to Art. 53 KR. The ...
Gothenburg, Sweden (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication. Poster# PP3.09 Today, data from a post hoc analysis of the three-year part of the phase 3a SCALE(TM) (Satiety and Clinical Adiposity - Liraglutide Evidence) ...
issuer: ams AG Tobelbader Strasse 30 A-8141 Unterpremstaetten phone: +43 3136 500-0 FAX: +43 3136 500-931211 mail: investor@ams.com WWW: www.ams.com sector: Technology ISIN: AT0000A18XM4 indexes: stockmarkets: official dealing: SIX Swiss Exchange language: English ...
company: voestalpine AG voestalpine-Straße 1 A-4020 Linz phone: +43 50304/15-9949 FAX: +43 50304/55-5581 mail: IR@voestalpine.com WWW: www.voestalpine.com sector: Metal Goods & Engineering ISIN: AT0000937503 indexes: WBI, ATX Prime, ATX stockmarkets: official market: Wien language: English ...
Gothenburg, Sweden (ots/PRNewswire) - Isofol Medical AB today announced initiation of the next dose level of Modufolin®, in combination with 5-FU and oxaliplatin or 5-FU and irinotecan, in the ongoing, incremental dose cohort, phase I/II clinical trial, ISO-CC-005. In total 16 patients with stage IV colorectal ...
New York and Toronto (ots/PRNewswire) - DH Corporation (http://dh.com/) (TSX: DH) ("D+H"), a leading provider of technology solutions to financial institutions globally, today announced that it will demonstrate its real-time payment capabilities at EBAday, an industry leading forum covering the key trends impacting the payments industry, on June 7-8 in Milan, Italy, ...
Vancouver, British Columbia (ots/PRNewswire) - - European listing to provide Company with global exposure - Company has secured 13 Drill Permits at Fish Valley Lithium Brine Project American Lithium Corp. (TSXV: Li; Frankfurt: 5LA) ("American Lithium" or the "Company"), is pleased to announce that its common shares ...
Lausanne, Switzerland (ots/PRNewswire) - Debiopharm International SA (Debiopharm), a Swiss-based company, part of Debiopharm Group(TM), today announced that the FDA Office of Orphan Products Development (OOPD) has granted Orphan Drug Designation to Debio 1143 for treatment of ovarian cancer. Orphan Drug Designation ...
issuer: voestalpine AG voestalpine-Straße 1 A-4020 Linz phone: +43 50304/15-9949 FAX: +43 50304/55-5581 mail: IR@voestalpine.com WWW: www.voestalpine.com sector: Metal Goods & Engineering ISIN: AT0000937503 indexes: WBI, ATX Prime, ATX stockmarkets: official market: Wien language: English ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Letter of Intent LifeWatch AG: LifeWatch turns the page on key legal matters 01.06.2016 / 18:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. 468329 01.06.2016 ...
Frankfurt am Main (ots) - - Sentiment among late and early-stage financiers deteriorates in the first quarter - However, prospects for market growth remain good Sentiment on the German private equity market has cooled significantly. The German Private Equity Barometer's business climate index fell 14.3 points to 45.4 balance points in the first quarter of 2016. The indicator for both segments of the market was down on the ...
company: UNIQA Insurance Group AG Untere Donaustraße 21 A-1029 Wien phone: 01/211 75-0 mail: investor.relations@uniqa.at WWW: http://www.uniqagroup.com sector: Insurance ISIN: AT0000821103 indexes: WBI, ATX Prime, ATX stockmarkets: official market: Wien language: English ...